news
Anti-PD-1 therapy linked to delayed onset of skin disease
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
List view / Grid view
Anti-Cancer Therapeutics
news
Blood test predicts treatment response for metastatic prostate cancer
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy...
news
Phenformin-mTOR inhibitor combination shows promise in HCC
A combination of mTOR inhibitors and Phenformin leads to an increase in overall survival...
news
SMC approves Xermelo for carcinoid syndrome diarrhoea
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
news
FDA accepts Larotrectinib New Drug Application and Grants Priority Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
news
DNA-based vaccine treatment for colorectal cancer to undergo first human study
Researchers hope immunotherapy will prevent against overactive immune response...
news
Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma
Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.
news
PET scan tracer predicts success of cancer vaccine
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
news
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
news
Cone beam CT offers detailed imaging for precise RS delivery
A novel technique called radiation segmentectomy (RS), that delivers high doses of radiation to tumours while sparing the surrounding healthy tissue, shows promise as a curative treatment option for patients with early-stage liver cancer, according to a recent study.
news
Vitamin A derivative selectively kills liver cancer stem cells
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma...
news
Combining drugs that target BRAF and HSP90 shows success for melanoma patients
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
news
Improved method of delivering anti-cancer drugs
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects...
news
Two-drug combination proves effective for most lung cancers
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
news
Combination immunotherapy improves survival in mouse models of mesothelioma
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
